Concurrent Investment Advisors, LLC Ice Cure Medical Ltd. Transaction History
Concurrent Investment Advisors, LLC
- $8.78 Trillion
- Q4 2025
A detailed history of Concurrent Investment Advisors, LLC transactions in Ice Cure Medical Ltd. stock. As of the latest transaction made, Concurrent Investment Advisors, LLC holds 78,285 shares of ICCM stock, worth $55,582. This represents 0.0% of its overall portfolio holdings.
Number of Shares
78,285Holding current value
$55,582% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding ICCM
# of Institutions
19Shares Held
443KCall Options Held
0Put Options Held
0-
Ubs Group Ag92.2KShares$65,4370.0% of portfolio
-
Two Sigma Securities, LLC New York, NY50.2KShares$35,6220.01% of portfolio
-
Hrt Financial LP New York, NY46.7KShares$33,1550.0% of portfolio
-
Geode Capital Management, LLC Boston, MA40.5KShares$28,7210.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il37.2KShares$26,3920.0% of portfolio
About IceCure Medical Ltd.
- Ticker ICCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 36,835,600
- Market Cap $26.2M
- Description
- IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.